More on PHRM
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $12.00 |
|
|||
| Open | $12.38 | ||||
| 52 Wk High | $72.32 | ||||
| 52 Wk Low | $1.25 | ||||
| Day High | $12.00 | ||||
| Day Low | $12.00 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 50,000 | ||||
- Medicus Pharma completes $2.97 million acquisition of Antev Limited
- Medicus Pharma Ltd. Completes Acquisition of Antev Limited
- PharmaTher receives FDA approval for ketamine product KETARx
- PharmaTher Announces FDA Approval of Ketamine (KETARx™)
- PharmaTher Applauds FDA's New Commissioner’s National Priority Voucher (CNPV) Program, Citing Potential to Accelerate its Ketamine Programs for Mental Health, Pain, and Neurological Disorders,
Entities mentioned with PHRM
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- SAC Capital | View Related Stories »
- Steven A. Cohen | View Related Stories »
- Earnings | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Dividend | View Related Stories »
- Show More...
